EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of glioma

Nayuta Higa, Toshiaki Akahane, Mari Kirishima, Hajime Yonezawa, Ryutaro Makino, Hiroyuki Uchida, Seiya Yokoyama, Tomoko Takajo, Ryosuke Otsuji, Yutaka Fujioka, Yuhei Sangatsuda, Daisuke Kuga und 8 weitere

Pathology - Research and Practice · 2024-11 · 263 · 155598

DOI: 10.1016/j.prp.2024.155598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024-11. Verfasst von Nayuta Higa und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 890-8520, J…. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previously, we constructed a DNA-based next-generation sequencing (NGS) panel for an integrated diagnosis of gliomas according to the 2021 World Health Organization classification system. The aim of the current study was to evaluate the feasibility of a modified panel to include fusion gene detection via RNA-based analysis. Using this bimodal DNA/RNA panel, we analyzed 210 cases of gliomas and others to identify fusion genes in addition to gene alterations, including TERT promoter (TERTp) mutation and 1p/19q co-deletion, in formalin-fixed paraffin-embedded tissues. Of the 210 patients, fusion genes were detected in tumors of 35 patients. Eighteen of 112 glioblastomas (GBs) harbored fusion genes, including EGFR and FGFR3 fusions. In IDH-mutant astrocytoma, 6 of 30 cases showed fusion genes such as MET and NTRK2 fusions. Eleven molecular GBs and 20 not-elsewhere-classified cases harbored no gene fusions. Other 11 tumors including ependymoma, pilocytic astrocytoma, diffuse hemispheric glioma, infant-type hemispheric glioma, and solitary fibrous tumors exhibited diagnostic fusion genes. Overall, our results suggest that the all-in-one bimodal DNA/RNA panel is reliable for detecting diagnostic gene alterations in accordance with the latest WHO classification. The integrative pathological and molecular strategy could be valuable in confirmation of diagnosis and selection of treatment options for brain tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsHigh-Throughput Nucleotide SequencingHumansMaleFemaleMiddle AgedAdultBiomarkers, TumorAgedYoung Adult

Stichwörter der Autor:innen

Bimodal DNA/RNA panelFusion geneGliomaIntegrative diagnosisNGS

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 890-8520, Japan.
  • Department of Pathology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 890-8544, Japan; Center for Human Genome and Gene Analysis, Kagoshima University Hos…
  • Department of Pathology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 890-8544, Japan.
  • Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Department of Neurosurgery, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasamamachi, Yufu, Oita 879-5593, Japan.
  • Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Higa, N., Akahane, T., Kirishima, M., Yonezawa, H., Makino, R., Uchida, H., Yokoyama, S., Takajo, T., Otsuji, R., Fujioka, Y., Sangatsuda, Y., Kuga, D., Yamahata, H., Hata, N., Horie, N., Kurosaki, M., Yamamoto, J., Yoshimoto, K., Tanimoto, A., & Hanaya, R. (2024). All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of glioma. Pathology - Research and Practice, 263, 155598. https://doi.org/10.1016/j.prp.2024.155598

Vancouver

Higa N, Akahane T, Kirishima M, Yonezawa H, Makino R, Uchida H, et al. All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of glioma. Pathology - Research and Practice. 2024;263:155598. doi:10.1016/j.prp.2024.155598

BibTeX
@article{Higa2024,
  author = {Higa, Nayuta and Akahane, Toshiaki and Kirishima, Mari and Yonezawa, Hajime and Makino, Ryutaro and Uchida, Hiroyuki and Yokoyama, Seiya and Takajo, Tomoko and Otsuji, Ryosuke and Fujioka, Yutaka and Sangatsuda, Yuhei and Kuga, Daisuke and Yamahata, Hitoshi and Hata, Nobuhiro and Horie, Nobutaka and Kurosaki, Masamichi and Yamamoto, Junkoh and Yoshimoto, Koji and Tanimoto, Akihide and Hanaya, Ryosuke},
  title = {All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of glioma},
  journal = {Pathology - Research and Practice},
  year = {2024},
  volume = {263},
  pages = {155598},
  doi = {10.1016/j.prp.2024.155598}
}
Kostenlos starten →